GovChime
Notice ID: 351029723bb4427daf28725c2213387eAward NoticeAwarded

Q--Clinical Genetic Testing for Undiagnosed Disease P

Awarded on September 15, 2023. Full description on SAM.gov.

Awarded tounder 75N92023P00362 (source: SAM.gov award notice)• $50.0K

Overview

Posted
September 15, 2023
Notice type
Award Notice
NAICS
622110: General Medical and Surgical Hospitals
Agency
Department of Health and Human Services

Notice details

Last updated
Dec 4, 2025
Award date
Sep 15, 2023
Award amount (SAM.gov award notice)
$50.0K

Identifiers

Solicitation number
75N92023Q0864
Notice ID
351029723bb4427daf28725c2213387e
Award number (PIID)
75N92023P00362

Description

Clinical Genetic Testing for Undiagnosed Disease Program

Full description on SAM.gov

Award Overview

Award Number

75N92023P00362

Award Amount (SAM.gov award notice)

$50.0K

Award Date

Sep 15, 2023

Awardee

Awardee UEI

EAEEYN1KBJT6

Awardee CAGE Code

324L3

Original Solicitation

Notice ID: 351029723bb4427daf28725c2213387e

Posted Date: Sep 15, 2023

Original Response Deadline: Not specified

More From This Vendor

Top 5 most recent

2
  • 75N98026P01230
    GREENWOOD GENETIC CENTER INC
    Department of Health and Human ServicesNAICS 621511
    $49.4KSigned Aug 10, 2026
  • 75N92025P00400
    GREENWOOD GENETIC CENTER INC
    Department of Health and Human ServicesNAICS 621511
    $49.4KSigned Sep 25, 2025

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75N92023Q0864
  1. Solicitation
  2. Awarded

This opportunity has been awarded.

  1. SolicitationAug 30, 2023

    Clinical Genetic Testing for Undiagnosed Disease P

    Notice 1e57b784095c42b3be1deb33f520f10e on SAM.gov

  2. AwardedCurrentSep 15, 2023

    Q--Clinical Genetic Testing for Undiagnosed Disease P

    Notice 351029723bb4427daf28725c2213387e on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
This is a notice of intent to award a sole source contract with Johns Hopkins Bayview Medical Center, Inc., to extend the period of performance for the clinical services and resources necessary to maintain the research operation of the NIDA IRP Clinical Research Program. The Government proposes to award an additional twelve (12) month contract with the period of performance: December 31, 2026 through January 31, 2027. The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted. Specifically, Johns Hopkins Bayview Medical Center is the only vendor in the marketplace that can provide the services required by NIDA.
-Combined Synopsis11/25/2026
This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with part 12. This announcement constitutes the only solicitation. Offers are being requested and a separate written solicitation will not be issued. Solicitation number 15BFA025R00000055 is issued as a Request for proposal (RFP), for Comprehemsive Medical Services. This acquisition is not set-aside for small business concerns. This solicitation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at www.acquisition.gov. (ii) Please see Section B in the attached solicitation for details regarding Line-Items. (iii) No brand name requirement for the items that are to be acquired. (iv) Services rendered will be provided at FCI Cumberland, located in Cumberland, Maryland. The date and times will be determined after award. Please see attached solicitation for details. (v) See solicitation for list of provisions. (vi) See solicitation for list of clauses. (vii) Offers shall be received via email (J2gregory@bop.gov and BOP-ADM-FAO-CMS-S@bop.gov) on or before the deadline as listed on the SF-33 Block 9. You may also contact us with any questions via the same email addresses. (viii) Please see below for Contracting Officer's contact information.
-Combined Synopsis12/09/2026
JOFOC for comprehensive medical services for FCI Cumberland. November 2026
-Sole Source / J&AOpen
NOTICE OF INTENT – SOLE-SOURCE ACQUISITION Notice No.: The National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS), intends to award a Firm-Fixed-Price Purchase Order to Creative Biolab Inc. for culture all cells and differentiate them, expand their cell populations to more than 20 million, collect them, verify cell count, and send them back to us. Description of the Requirement The primary objective of this study is to sequence and analyze the 4q35 locus on Chromosome 4 for several years. This locus is a gene-poor and extremely long (>100K) region of DNA that consists of many repetitive sequences which makes sequencing and analysis extremely difficult. To sequence this locus using Nanopore Sequencing technology. To expand the number of samples for our experiment, we looked for a company that can handle numerous cell lines and follow the protocol that we provide. Creative Biolabs is the only company/research institute that has been able to perform differentiation within 3 months and has the ability to follow our protocol with numerous cell lines. Justification for the Proposed Sole-Source Acquisition The Government intends to solicit from a single source pursuant to FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. Only Creative Biolabs was willing to follow our exact protocol and had the logistical capacity to handle the large number of cell lines that we need to analyze, which is vital to research at the National Institute of Environmental Health Sciences. Response Information This notice is not a request for competitive quotations or proposals. However, interested parties that believe they can meet the Government's requirements may submit a capability statement demonstrating their ability to provide the required preventive maintenance and remedial repair services for the specified instrument and meet all applicable technical and operational requirements. The Government will review timely submissions to determine whether another responsible source is capable of satisfying the requirement and whether a competitive acquisition is appropriate. The Government anticipates making an award approximately five (5) calendar days after the closing date of this notice, unless the Government determines that another responsible source can satisfy the requirement. Capability statements must be submitted electronically to verne.griffin@nih.gov no later than 9:00 a.m. EDT on November 13, 2026. Please reference Notice No. 75N98027Q00053 in the subject line of the submission.
-Pre-Solicitation11/12/2026
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98026Q01209/PCA-NIA-08501. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm fix-price award on a non-competitive basis to Epigenetic Clock Development Foundation 1124 W. Carson Street, MRL Bldg., 3rd Floor Torrance, CA 90502 US to provide obtain DNA methylation profiling and epigenetic age analysis for 320 previously extracted murine DNA samples using the Mammal320K methylation array and established Horvath epigenetic clock methodologies.
-Combined Synopsis09/23/2026

Additional Details

Solicitation Number

75N92023Q0864

Archive Date

Sep 30, 2023

Office Address

BETHESDA, MD, 20892